• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

六邻体嵌合腺病毒的构建与特性:腺病毒血清型的确定

Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.

作者信息

Gall J G, Crystal R G, Falck-Pedersen E

机构信息

Department of Microbiology, W. R. Hearst Research Foundation, Cornell University Medical College, New York, New York 10021, USA.

出版信息

J Virol. 1998 Dec;72(12):10260-4. doi: 10.1128/JVI.72.12.10260-10264.1998.

DOI:10.1128/JVI.72.12.10260-10264.1998
PMID:9811772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC110610/
Abstract

This study has used the strategy of gene replacement to characterize the contribution of the adenovirus (Ad) capsid protein hexon to serotype definition. By replacing the Ad type 5 (Ad5) hexon gene with sequences from Ad2, we have changed the type specificity of the chimeric virus. The type-determining epitopes are primarily associated with loop 1 of hexon and, to a much lesser degree, with loop 2. In spite of the serotype distinctiveness of the chimeric hexon viruses, epitope similarity between the vectors resulted in a low level of cross-reactive neutralizing antibody, which in combination with activated cellular and innate arms of the immune system is sufficient to suppress gene transduction following readministration in vivo.

摘要

本研究采用基因置换策略来表征腺病毒(Ad)衣壳蛋白六邻体对血清型定义的贡献。通过用Ad2的序列替换Ad5六邻体基因,我们改变了嵌合病毒的型特异性。决定血清型的表位主要与六邻体的环1相关,在较小程度上与环2相关。尽管嵌合六邻体病毒具有血清型独特性,但载体之间的表位相似性导致交叉反应性中和抗体水平较低,这与免疫系统的激活细胞和固有分支相结合,足以在体内再次给药后抑制基因转导。

相似文献

1
Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.六邻体嵌合腺病毒的构建与特性:腺病毒血清型的确定
J Virol. 1998 Dec;72(12):10260-4. doi: 10.1128/JVI.72.12.10260-10264.1998.
2
Use of chimeric adenoviral vectors to assess capsid neutralization determinants.使用嵌合腺病毒载体评估衣壳中和决定簇。
Virology. 2005 Mar 15;333(2):207-14. doi: 10.1016/j.virol.2004.12.029.
3
Expression of an antigenic adenovirus epitope in a group B coxsackievirus.B组柯萨奇病毒中一种抗原性腺病毒表位的表达
J Virol. 2000 May;74(10):4570-8. doi: 10.1128/jvi.74.10.4570-4578.2000.
4
Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.5型和7型腺病毒衣壳嵌合体:纤维替换改变受体嗜性而不影响主要免疫中和表位。
J Virol. 1996 Apr;70(4):2116-23. doi: 10.1128/JVI.70.4.2116-2123.1996.
5
Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.用于生产病毒型特异性抗体的小尺寸重组腺病毒六邻体蛋白片段。
Virol J. 2017 Aug 18;14(1):158. doi: 10.1186/s12985-017-0822-5.
6
Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon.构建并鉴定由 7 型腺病毒五邻体包装的 3 型人腺病毒。
Virus Res. 2011 Sep;160(1-2):214-20. doi: 10.1016/j.virusres.2011.06.017. Epub 2011 Jun 29.
7
Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon.通过5型腺病毒六邻体的X射线晶体学研究揭示的型特异性表位位置。
Mol Ther. 2000 Jan;1(1):18-30. doi: 10.1006/mthe.1999.0001.
8
Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.由3型六邻体包装的5型腺病毒的构建与特性分析
J Virol. 2002 Dec;76(24):12775-82. doi: 10.1128/jvi.76.24.12775-12782.2002.
9
Alternate adenovirus type-pairs for a possible circumvention of host immune response to recombinant adenovirus vectors.
Acta Microbiol Immunol Hung. 2001;48(2):143-6.
10
Characterization of adenovirus hexons by their epitope composition.通过腺病毒六邻体的表位组成对其进行表征。
Arch Virol. 1996;141(10):1891-907. doi: 10.1007/BF01718202.

引用本文的文献

1
Characterization of Human Viral Diversity and Adenovirus Isolates in a Sewage Treatment Plant in Tianjin: Implications for Public Health and Advanced Monitoring.天津某污水处理厂中人类病毒多样性及腺病毒分离株的特征分析:对公共卫生和高级监测的启示
Food Environ Virol. 2025 Jul 12;17(3):39. doi: 10.1007/s12560-025-09654-2.
2
Characterization of Human Adenoviruses of Medical Importance: Isolation of Infectious Virus from Clinical Specimens and Molecular Typing.医学重要性人类腺病毒的特性:从临床标本中分离感染性病毒和分子分型。
Curr Protoc. 2023 Nov;3(11):e916. doi: 10.1002/cpz1.916.
3
Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo.腺病毒 C 六邻体与凝血酶原的结合及其对载体性质的影响:体内外研究。
PLoS Pathog. 2022 Sep 26;18(9):e1010859. doi: 10.1371/journal.ppat.1010859. eCollection 2022 Sep.
4
Species Consists of a Single Serotype despite Genetic Distance of FAdV-5 Isolates.尽管 FAdV-5 分离株的遗传距离很大,但仍由单一血清型组成。
Viruses. 2022 Jan 27;14(2):248. doi: 10.3390/v14020248.
5
Immunological Study of Reconstructed Common Ancestral Sequence of Adenovirus Hexon Protein.腺病毒六邻体蛋白重建共同祖先序列的免疫学研究
Front Microbiol. 2021 Oct 27;12:717047. doi: 10.3389/fmicb.2021.717047. eCollection 2021.
6
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines.用于开发下一代流感疫苗的基于腺病毒载体的疫苗平台。
Vaccines (Basel). 2020 Oct 1;8(4):574. doi: 10.3390/vaccines8040574.
7
Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors.用于体内递送CRISPR-Cas基因编辑器的腺病毒载体。
J Control Release. 2020 Nov 10;327:788-800. doi: 10.1016/j.jconrel.2020.09.003. Epub 2020 Sep 3.
8
A multigene typing system for human adenoviruses reveals a new genotype in a collection of Swedish clinical isolates.一种用于人类腺病毒的多基因分型系统揭示了瑞典临床分离株中的一种新基因型。
PLoS One. 2018 Dec 14;13(12):e0209038. doi: 10.1371/journal.pone.0209038. eCollection 2018.
9
Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration.针对腺病毒纤维和五邻体基底蛋白的抗体可抑制全身给药后肝脏中腺病毒载体介导的转导。
Sci Rep. 2018 Aug 17;8(1):12315. doi: 10.1038/s41598-018-30947-z.
10
Progress in Adenoviral Capsid-Display Vaccines.腺病毒衣壳展示疫苗的进展
Biomedicines. 2018 Jul 26;6(3):81. doi: 10.3390/biomedicines6030081.

本文引用的文献

1
PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.用5型腺病毒可溶性抗原产生特异性中和抗体
Proc Soc Exp Biol Med. 1963 Oct;114:37-42. doi: 10.3181/00379727-114-28579.
2
Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.人类对腺病毒重组衣壳蛋白的免疫反应:抗纤维抗体和抗五聚体基底抗体对中和活性具有协同作用。
J Virol. 1998 Mar;72(3):2388-97. doi: 10.1128/JVI.72.3.2388-2397.1998.
3
Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.肿瘤坏死因子α在腺病毒载体的免疫介导清除过程中发挥核心作用。
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9814-9. doi: 10.1073/pnas.94.18.9814.
4
The role of antibody concentration and avidity in antiviral protection.抗体浓度和亲和力在抗病毒保护中的作用。
Science. 1997 Jun 27;276(5321):2024-7. doi: 10.1126/science.276.5321.2024.
5
Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.通过给予不同血清型的腺病毒载体规避抗腺病毒中和免疫。
Hum Gene Ther. 1997 Jan 1;8(1):99-109. doi: 10.1089/hum.1997.8.1-99.
6
Circumventing the immune response to adenovirus-mediated gene therapy.规避对腺病毒介导的基因治疗的免疫反应。
Gene Ther. 1996 Feb;3(2):154-62.
7
"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.“血清型转换”腺病毒介导的体内基因转移:通过改变腺病毒血清型规避针对重复腺病毒载体给药的抗腺病毒体液免疫防御。
Hum Gene Ther. 1996 Jan;7(1):79-87. doi: 10.1089/hum.1996.7.1-79.
8
Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.5型和7型腺病毒衣壳嵌合体:纤维替换改变受体嗜性而不影响主要免疫中和表位。
J Virol. 1996 Apr;70(4):2116-23. doi: 10.1128/JVI.70.4.2116-2123.1996.
9
Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues.对15种腺病毒六邻体蛋白的分析揭示了七个含有血清型特异性残基的高变区的位置和结构。
J Virol. 1996 Mar;70(3):1836-44. doi: 10.1128/JVI.70.3.1836-1844.1996.
10
The hexon genes of adenoviruses of subgenus C: comparison of the variable regions.C亚属腺病毒的六邻体基因:可变区比较
Res Virol. 1993 Mar-Apr;144(2):117-27. doi: 10.1016/s0923-2516(06)80020-8.